Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus
Clinical trial NCT05664750 · COMPLETED
Trial details
- NCT number
- NCT05664750
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-22
- Primary completion
- 2023-03-24
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.